Person:
AKGÜLLE, AHMET HAMDİ

Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

OrgUnit Logo
Organizational Unit

Job Title

Last Name

AKGÜLLE

First Name

AHMET HAMDİ

Name

Filters

20211
Reset filters

Settings

Author: KARADAĞ SAYGI, NAİME EVRİM × Has files: false ×

Search Results

Now showing 1 - 2 of 2
  • No Thumbnail Available
    PublicationMetadata only
    Serebral palside botulinum toksin enjeksiyon tedavisinin artısı ve eksisi: bakım verenlerin perspektifini inceleyen niteliksel bir çalışma
    (2021-02-28) KARADAĞ SAYGI, NAİME EVRİM; KENİŞ COŞKUN, ÖZGE; CÖBEK ÜNALAN, GÜLRU PEMRA; AKGÜLLE, AHMET HAMDİ; KARADAĞ SAYGI N. E., KENİŞ COŞKUN Ö., CÖBEK ÜNALAN G. P., EVKAYA ACAR A., AKGÜLLE A. H., GİRAY E.
  • No Thumbnail Available
    PublicationMetadata only
    Pros and cons of botulinum toxin injection therapy in cerebral palsy: A qualitative study exploring caregivers' perspective
    (WILEY) AKGÜLLE, AHMET HAMDİ; Karadag-Saygi, Evrim; Kenis-Coskun, Ozge; Unalan, Pemra C.; Evkaya-Acar, Ayca; Giray, Esra; Akgulle, Ahmet Hamdi
    Background To describe and understand the experiences and beliefs of caregivers of children with cerebral palsy following botulinum toxin injection. Methods A descriptive case study approach with focus group interviews was employed. A semi-structured questionnaire was conducted to collect data. Twenty-one caregivers of children (3-13 years old) with cerebral palsy were recruited with a maximum variation sampling strategy to gain insight through different perspectives. Qualitative analysis with verbatim transcripts was analysed using a thematic approach. Findings Four themes emerged from qualitative analyses: acceptance of diagnosis, perceptions about treatment, caregivers' experiences with the health environment, and feelings and thoughts after the treatment. Conclusions This study highlights caregivers' requests for information about the possible long-term effect of botulinum toxin, as well as information and support to provide the best rehabilitation programme immediately after injection.